An observational study in Arthroplasty Complications, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 85 Years and older. Per ClinicalTrials.gov, last updated 2023-08-01.
Sponsored by Central Hospital, Nancy, France · Observational
Retrospective, single-centre study. Review of patients aged 85 and over who underwent total hip replacement between June 2015 and February 2022.
This is a femoral stem survival study with calculation of the complication rate in this population.
The study does not focus on total hip replacements in the context of trauma. The secondary endpoint was the search for complication risk factors.
Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Any people of 85 years of more who received total hip arthroplasty with uncemented stem fully hydroxyapatitis coated
Exclusion Criteria:
Procedure: Total hip arthroplasty
rate of complication
survival study, any complications
Time frame: minimum of 3 months follow up
risk factor of complications
Time frame: minimum of 3 months follow up
This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France